On June 15, Axinn partner Chad Landmon participated in the panel, “The Future of Skinny Labeling and Its Impact on Generics and Biosimilars” at the 2022 FDLI Annual Conference.

Founded in 1949, the Food and Drug Law Institute (FDLI) is a nonprofit membership organization that offers education, training, publications, and professional engagement opportunities in the field of food and drug law.

Click here for more information.